On Thursday, December 3, NPWH along with 15 stakeholders attended the meeting, including American Academy of Pediatrics, American Congress of Obstetricians and Gynecologists, Society for Maternal-Fetal Medicine, Society for Women’s Health Research, and Association of Women’s Health, Obstetric and Neonatal Nurses, American College of Nurse Midwives attended the Coalition to Advance Maternal Therapeutics Stakeholder Meeting.
The meeting focused on the new FDA pregnancy and lactation labeling rule with a history of pregnancy labeling, problems with the old system, processes used to develop new labeling rule, and examples of the requirements of the new labeling rule. The CDC presented on the Treating for Two initiative, the magnitude of medication use in pregnancy, and the objectives of the program. The objectives of Treating for Two include:
- Reduce fetal exposure to tetratogenic medications,
- Prevent birth defects and other adverse pregnancy outcomes,
- Improve women’s health by informing safe and effective treatment of conditions during pregnancy and the reproductive years
- Increase confidence in using medications during pregnancy that are not associated with adverse outcomes
Learn more about the Treating for Two initiative here.